SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

CrowdStrike is seeing high volatility following a quarterly earnings report that exceeded expectations but fell short of the elevated growth targets demanded by the market, leading investors to lock in profits after a massive rally. The community is actively discussing the impact of the newly announced 4-for-1 stock split and debating whether the recent dip represents a healthy consolidation or the start of a deeper valuation correction.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera Hashgraph is currently driving heated debate as investors weigh its enterprise utility against ongoing concerns regarding high token dilution and stagnant price action. While some community members are aggressively accumulating during current dips, others remain skeptical, citing a lack of meaningful revenue and questioning the long-term ROI for retail holders.

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

Pudgy Penguins is trending as investors debate its potential to transition from a niche digital project into a mainstream brand through retail expansion and new product integrations. While some users express frustration over stagnant price action compared to other assets, the community remains actively divided between those highlighting its tangible revenue and 'phygital' business model and those skeptical of its long-term performance.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is currently trending as investors debate its long-term potential, with bulls citing its post-quantum cryptography capabilities and potential adoption in tokenized finance as reasons to accumulate at current support levels. Meanwhile, the community remains polarized, with many skeptical of its extended consolidation and historical underperformance, leading to intense discussions about whether the asset is a undervalued utility or a long-term trap.

SPX6900 is an advanced blockchain cryptography token coin capable of limitless possibilities and scientific utilization.

SPX6900

SPX6900 is trending as the community doubles down on long-term conviction, framing the asset as a 'pure belief' meme coin alternative to traditional market indices. Investors are actively discussing DCA strategies and relative strength during market volatility while drawing comparisons to past meme coin cycles.

Lighter is a decentralized trading platform built for unmatched security and scale. It’s the first exchange to offer verifiable order matching and liquidations while delivering best-in-class performance on par with traditional exchanges.

lighter

Lighter (LIT) is capturing market attention following a significant tokenomics overhaul that includes a series of revenue-funded token burns and deeper integration with Robinhood. Community discussions are heavily focused on the protocol's rising trading volume and its role as a high-performance decentralized perpetual exchange, with many participants debating its potential to compete with major rivals like Hyperliquid.

Direxion Shares ETF Trust - Direxion Daily Technology Bull 3X ETF

Direxion Daily Technology Bull 3X Shares

The Direxion Daily Technology Bull 3X Shares is seeing active discussion as traders analyze recent technical signals like bullish engulfing patterns and potential breakout levels to navigate its inherent volatility. Community members remain polarized, balancing long-term bullish outlooks with cautious strategies involving profit-taking, hedging against potential market cycles, and reacting to semiconductor and broader tech sector performance.

J.P. Morgan Exchange-Traded Fund Trust - JPMorgan Nasdaq Equity Premium Income ETF

JPMorgan Nasdaq Equity Premium Income ETF

JEPQ is drawing significant investor interest as a core holding for monthly income, with the community actively debating its performance relative to other covered-call ETFs and the long-term sustainability of its dividend yield. Discussion currently centers on balancing capital appreciation with income consistency, leading many to leverage the fund as a cornerstone for building long-term, passive wealth.

WhiteFiber, Inc. provides AI and HPC infrastructure & cloud and data center solutions. It operates through the following segments: Cloud Services and Colocation Services. The Cloud Services segment offers computing services to support generative AI workstreams. The Colocation Services segment provides customers with physical space, power and cooling within the data center facility. The company was founded on August 15, 2024 and is headquartered in New York, NY.

Whitefiber Inc.

WhiteFiber, Inc.

WhiteFiber, Inc. is trending as investors focus on its pivot to high-performance AI infrastructure, bolstered by a significant new $160 million AI compute agreement and growing institutional interest in its data center expansion strategy. The community is actively discussing the stock's low float and the strategic value of its parent company's stake, keeping the focus on potential upside as it scales compute capacity and captures demand for specialized AI workloads.

Harvest Portfolios Group Inc - Harvest Diversified High Income Shares ETF (Class A Units)

Investors are closely tracking HHIS as Canadian participants continue to prioritize the ETF for its tax-efficient monthly income distributions and diversified exposure to high-growth tech equities. Community sentiment remains focused on using the fund as a core compounding vehicle, often reinvesting payouts from other yield-focused strategies to build long-term holdings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Prime Medicine Secures Favorable Arbitration Ruling in Beam Therapeutics Case

Prime Medicine won arbitration with Beam Therapeutics over PM647, avoiding damages and keeping its AATD gene-editing program on track.read more...

PRME Surges 15% After Winning Arbitration Against Beam — Clears Path To Human Trials For Its Gene-Editing Drug

Equity

An independent arbitration panel ruled that developing Prime Medicine’s experimental drug for Alpha-1 Antitrypsin Deficiency falls within its rights under a 2019 collaboration agreement with Beam Therapeutics. 


Here's Why H.C. Wainwright Upgraded Prime Medicine (PRME) To "Buy"

Here's Why H.C. Wainwright Upgraded Prime Medicine (PRME) To "Buy...

Foghorn Therapeutics (FHTX) Surges 5.8%: Is This an Indication of Further Gains?

Foghorn Therapeutics (FHTX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Ocular Therapeutix vs. Prime Medicine: Which Healthcare Stock Is a Better Buy in 2026?

Key PointsOcular Therapeutix is transitioning into a major player in the retinal disease market with its lead program, Axpaxli...

Prime Medicine, Inc. (PRME) Reports Q1 Loss, Misses Revenue Estimates

Prime Medicine, Inc. (PRME) delivered earnings and revenue surprises of -15.99% and -45.13%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

RenovoRx, Inc. (RNXT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

RenovoRx (RNXT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Harmony Biosciences Holdings, Inc. (HRMY) Q1 Earnings and Revenues Miss Estimates

Harmony Biosciences (HRMY) delivered earnings and revenue surprises of -27.94% and -3.18%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Prime Medicine (NASDAQ:PRME) Upgraded to Sell at Wall Street Zen

Wall Street Zen raised shares of Prime Medicine from a "strong sell" rating to a "sell" rating in a research note on Tuesday...

Prime Medicine (NASDAQ:PRME) Stock Rating Lowered by Wall Street Zen

Wall Street Zen downgraded shares of Prime Medicine from a "sell" rating to a "strong sell" rating in a research report on Monday...

Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.

Prime Medicine Inc

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

PRMEPrime Medicine Inc

Fundamentals

Latest PRME News